In this study, MBELNs were used to treat DSS-induced colitis and resulted in significant improvement against gut-related inflammatory disease via the aryl hydrocarbon receptor (AhR)/constitutive photomorphogenic homolog subunit 8 (COPS8) pathway (Sriwastva et al., 2022). This evidence concerns the gene AHR and colitis.